Obecabtagene autoleucel (obe-cel, AUTO1) for relapsed/refractory adult B-cell acute lymphoblastic leukemia (R/R B-ALL): Pooled analysis of the ongoing FELIX phase Ib/II study Meeting Abstract


Authors: Roddie, C.; Sandhu, K. S.; Tholouli, E.; Shaughnessy, P.; Barba, P.; Guerreiro, M.; Bishop, M. R.; Yared, J. A.; Ghobadi, A.; Yallop, D.; Logan, A. C.; Beitinjaneh, A. M.; Pantin, J. M.; Arellano, M.; Chaganti, S.; Malladi, R.; Menne, T.; Gómez, V. E.; Hodby, K.; Gundabolu, K.; Mountjoy, L.; O'Dwyer, K. M.; Abedin, S.; Alkhateeb, H.; Shah, B. D.; Lao-Sirieix, P.; Pittari, G.; Saxena, K.; Zhang, Y.; Brugger, W.; Pule, M. A.; Park, J. H.; DeAngelo, D. J.; Jabbour, E.
Abstract Title: Obecabtagene autoleucel (obe-cel, AUTO1) for relapsed/refractory adult B-cell acute lymphoblastic leukemia (R/R B-ALL): Pooled analysis of the ongoing FELIX phase Ib/II study
Meeting Title: 65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 142
Issue: Suppl. 1
Meeting Dates: 2023 Dec 9-12
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2023-11-02
Start Page: 222
Language: English
ACCESSION: WOS:001159306700223
DOI: 10.1182/blood-2023-179454
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jae Hong Park
    356 Park